Anonymous
Guest
Anonymous
Guest
Correct me if I am wrong here, but wouldn't they have halted the study if there was an apparent risk of death, or increased harm with Zetia vs. other arms? Furthermore, wouldn't the study have been stopped early if there was clearly a very significant reduction in events/mortality rates in the Zetia arm? Therefore, it seems to reason there is going to be either no benefit or slight benefit in outcomes data. All of which could be partly related to the study design.
You are correct Sir (RIP, Ed) !